- Home
- AISP vs ACHV Comparison
AISP vs ACHV Comparison
Compare AISP & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AISP
- ACHV
- Stock Information
- Founded
- AISP 2006
- ACHV N/A
- Country
- AISP United States
- ACHV United States
- Employees
- AISP N/A
- ACHV N/A
- Industry
- AISP Blank Checks
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- AISP Finance
- ACHV Health Care
- Exchange
- AISP Nasdaq
- ACHV Nasdaq
- Market Cap
- AISP 145.9M
- ACHV 167.6M
- IPO Year
- AISP N/A
- ACHV N/A
- Fundamental
- Price
- AISP $3.54
- ACHV $4.58
- Analyst Decision
- AISP Strong Buy
- ACHV Strong Buy
- Analyst Count
- AISP 1
- ACHV 1
- Target Price
- AISP $6.00
- ACHV $12.00
- AVG Volume (30 Days)
- AISP 827.6K
- ACHV 2.2M
- Earning Date
- AISP 11-05-2025
- ACHV 11-06-2025
- Dividend Yield
- AISP N/A
- ACHV N/A
- EPS Growth
- AISP N/A
- ACHV N/A
- EPS
- AISP N/A
- ACHV N/A
- Revenue
- AISP $13,724,085.00
- ACHV N/A
- Revenue This Year
- AISP $34.52
- ACHV N/A
- Revenue Next Year
- AISP $59.54
- ACHV N/A
- P/E Ratio
- AISP N/A
- ACHV N/A
- Revenue Growth
- AISP N/A
- ACHV N/A
- 52 Week Low
- AISP $2.25
- ACHV $1.84
- 52 Week High
- AISP $7.66
- ACHV $5.78
- Technical
- Relative Strength Index (RSI)
- AISP 30.27
- ACHV 53.79
- Support Level
- AISP $3.82
- ACHV $4.26
- Resistance Level
- AISP $4.20
- ACHV $5.42
- Average True Range (ATR)
- AISP 0.30
- ACHV 0.36
- MACD
- AISP -0.08
- ACHV -0.10
- Stochastic Oscillator
- AISP 4.86
- ACHV 28.02
About AISP Airship AI Holdings Inc.
Airship AI Holdings Inc is a robust AI-driven data management platform that solves complex data challenges for large institutions operating in dynamic and mission-critical environments with rapidly increasing volumes of data being ingested from a similarly rapidly growing number of data sources. Its primary offerings include Outpost AI, Acropolis, and Airship Command. Its offerings allow customers to manage their data across the full data lifecycle, when and where need it, using a secure permission-based architecture.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.